Human Papillomavirus-Related Malignant Neoplasm

Human Papillomavirus-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

168 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 70
Recruiting: 37
Ph III recruiting: 2
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05976828	IBRX-042 In Participants With HPV-Associated Tumors	active not recruiting	Phase 1	12	ImmunityBio, Inc.INDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT05108870	TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers	active not recruiting	Phase 1 / Phase 2	35	University of ChicagoOTHER	1	Apr 24, 2026	clinicaltrials